Immune response to lipopolysaccharide in primary biliary cirrhosis and autoimmune diseases

Journal of Autoimmunity

Volumn 22, Issue 2, 2004, Pages 153-158

  Ballot, Eric ^a   Bandin, Olivia ^a,b   Chazouilleres, Olivier ^a   Johanet, Catherine ^a   Poupon, Raoul ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b Hopital Saint Camille   (France)

Author keywords

Anti lipid A antibody; Endotoxin; Innate immunity; Primary biliary cirrhosis; Ursodeoxycholic acid

Indexed keywords

IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDE; URSODEOXYCHOLIC ACID;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BILIARY CIRRHOSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; EPITHELIUM CELL; FEMALE; HUMAN; IMMUNE RESPONSE; KUPFFER CELL; LIVER CELL; MALE; PRIORITY JOURNAL;

EID: 1342329687     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaut.2003.11.002     Document Type: Article

References (35)

1. Fussey S.P.M., Guest J.R., James O.F.W., Bassendine M.F., Yeaman S.J. Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc Natl Acad Sci U S A. 85:1988;8654-8658.
2. Harada K., Koichi T., Sudo Y., Masuda S., Nakanuma Y. Molecular identification of bacterial 16S ribosomal RNA gene in liver tissue of primary biliary cirrhosis. Is propioni-bacterium acnes involved in granuloma formation? Hepatology. 33:2001;530-536.
3. Kreisel W., Siegel A., Bahler A., Spamer C., Schietz E., Kist M., et al. Hight prevalence of autoantibodies to calreticulin of the IgA class in primary biliary cirrhosis: a possible role of gut-derived bacterial antigens in its aetiology? Scand J Gastroenterol. 34:1999;623-628.
4. Butler P., Valle F., Hamilton Miller J.M., Brumfitt W., Baum H., Burroughs A.K. M2 mitochondrial antibodies and urinary rough mutant bacteria in patients with primary biliary cirrhosis and in patients with recurrent bacteria. J Hepatol. 17:1993;408-414.
5. Butler P., Hamilton Miller J.M., McIntyre N., Burroughs A.K. Natural history of bacteriuria in women with primary biliary cirrhosis and the effect of antimicrobial therapy in symptomatic and asymptomatic groups. Gut. 36:1995;931-934.
6. Vilagut L., Vila J., Vinos O., Pares A., Gines A., Jimenez de Anta M.T., et al. Cross reactivity of anti-mycobacterium gordonae antibodies with the major mitochondrial autoantigens in primary biliary cirrhosis. J Hepatol. 21:1994;673-677.
7. Nolan J.P. Intestinal endotoxins as mediators of hepatic injury: an idea whose time has come again. Hepatology. 10:1989;887-891.
8. Mimura Y., Sakisaka S., Harada M., Sata M., Tanikawa K. Role of hepatocytes in direct clearance of lipopolysaccharide in rats. Gastroenterology. 109:1995;1969-1976.
9. Hopf U., Möller B., Stemerowicz R., Lobeck H., Rodloff A., Freudenberg M., et al. Relation between Escherichia coli R (Rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis. Lancet. 16:1989;1419-1421.
10. Sakisaka S., Koga H., Sasatomi K., Mimura Y., Kawaguchi T., Tanikawa K. Biliary secretion of endotoxin and pathogenesis of primary biliary cirrhosis. Yale J Biol Med. 70:1997;403-408.
11. Sasatomi K., Noguchi K., Sakisaka S., Sata M., Tanikawa K. Abnormal accumulation of endotoxin in biliary epithelial cellsin primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol. 29:1998;409-416.
12. Fussey S.P.M., Ali S.T., Guest J.R., James O.F.W., Bassendine M.F., Yeaman S.J. Reactivity of primary biliary cirrhosis sera with E. coli dihydrolipoamine acetyl transferase (E2p); characterization of the main immunogenic region. Proc Natl Acad Sci U S A. 87:1990;3987-3991.
13. Poltorak A., Ricciardi-Castagnoli P., Citterio A., Beutler B. Physical contact between LPS and Tlr4 revealed by genetic complementation. Proc Natl Acad Sci U S A. 97:2000;2163-2167.
14. Aderem A., Ulevitch R.J. Toll-like receptors in the induction of the innate response. Nature. 405:2000;782-787.
15. Ide T., Sata M., Nakano H., Suzuki H., Tanikawa K. Increased serum IgM class anti-lipid A antibody and therapeutic effect of ursodeoxycholic acid in primary biliary cirrhosis. Hepatogastroenterology. 44:1997;409-416.
16. Ludwig J., Dickson E.R., McDonald G.S. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol. 379:1978;103-112.
17. Flannery G.R., Burroughs A.K., Butler P., Chelliah J., Hamilton-Miller J.M.T., Brumfitt W., et al. Antimitochondrial antibodies in primary biliary cirrhosis recognize both specific peptides and shared epitopes of the M2 family of antigens. Hepatology. 10:1989;370-374.
18. Poupon R., Chazouillères O., Poupon R.E. Chronic cholestatic diseases. J Hepatol. 32:2000;129-140.
19. Masanaga T., Watanabe Y., Van de Water J., Leung P.S.C., Nakanishi T., Kajiyama G., et al. Induction and persistence of immune-mediated cholangiohepatitis in neonatally thymectomized mice. Clin Immunol Immunopathol. 89:1998;141-149.
20. Takahashi M., Ogasawara K., Takeda K., Hashimoto W., Sakihara H., Kumagai K., et al. LPS induces NK1.1+alpha beta T cell with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells. J Immunol. 156:1996;2436-2442.
21. Dobashi H., Seki S., Habu Y., Ohkawa T., Takeshita S., Hiraide H., et al. Activation of mouse liver natural killer cells and NK1.1+T cells by bacterial superantigen-primed Kupffer cells. Hepatology. 30:1999;430-436.
22. Doherty D.G., O'Farrelly. Innate and adaptive lymphoid cells in the human liver. Immunol Rev. 174:2000;5-20.
23. Spada F.M., Koezuka Y., Porcelli S.A. CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J Exp Med. 188:1998;1529-1534.
24. Tsuneyama K., Yasoshima M., Harada K., Hiramatsu K., Gershwin E., Nakanuma Y. Increased CD1d expression on small bile duct epithelium and epithelioid granuloma in livers in primary biliary cirrhosis. Hepatology. 28:1998;620-623.
25. Poelstra K., Bakker W.W., Klok P.A., Kamps J.A.A.M., Hardonk M.J., Meijer D.K.F. Dephosphorylation of endotoxin by alkaline phosphatase in vivo. Am J Pathol. 151:1997;1163-1169.
26. Medina J.F., Martinez-Anso E., Vazquez J.J., Prieto J. Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis. Hepatology. 25:1997;12-17.
27. Lazaron V., Leslie D.B., Wasiluk K.R., Dunn D.L. Accelerated internalization and detoxification of endotoxin by anti-lipopolysaccharide antibody is an Fc receptor-mediated process. Surgery. 130:2001;192-197.
28. Ekdahl K.N., Lööf L., Nyberg A., Nilsson U.R., Nilsson B. Defective Fc receptor-mediated clearance in patients with primary biliary cirrhosis. Gastroenterology. 101:1991;1076-1082.
29. Ingalls R.R., Heine H., Lien E., Yoshimura A., Golenbock D. Lipopolysaccharide recognition, CD14, and lipopolysaccharide receptors. Infect Dis Clin North Am. 13:1999;341-353.
30. Su G.L., Klein R.D., Aminlari A., Zhang H.Y., Steinstraesser L., Alarcon W.H., et al. Kupffer cell activation by lipopolysaccharide binding protein and toll-like receptor 4. Hepatology. 31:2000;932-936.
31. Pugin J., Schurer-Maly C.C., Leturcq D., Moriarty A., Ulevitch R.J., Tobias P.S. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci U S A. 90:1993;2744-2748.
32. Su G.L., Dorko K., Strom S.C., Nüssler A.K., Wang S.C. CD14 expression and production by human hepatocytes. J Hepatol. 31:1999;435-442.
33. Poupon R.E., Lindor K.D., Cauch-Dudek K., Dickson E.R., Poupon R., Heathcote E.J. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology. 113:1997;884-890.
34. Poupon R.E., Bonnand A.M., Chretien Y., Poupon R., UDCA-PBC Study Group. Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. Hepatology. 29:1999;1668-1671.
35. Schwarzenberg S.J., Bundy M. Ursodeoxycholic acid modifies gut-derived endotoxemia in neonatal rats. Pediatr Res. 35:1994;214-217.